Predictive factors for relapse in patients on buprenorphine maintenance. - Wikidata - awgldk - TriplyDB

Predictive factors for relapse in patients on buprenorphine maintenance.

Predictive factors for relapse in patients on buprenorphine maintenance.

http://www.wikidata.org/entity/Q37580637

about

Spiritual Well-Being and Associated Factors with Relapse in Opioid Addicts.New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine.Long-term retention in Office Based Opioid Treatment with buprenorphine.An overview of available drugs for management of opioid abuse during pregnancy.Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities.Factors associated with non-adherence to Buprenorphine-naloxone among opioid dependent African-Americans: A retrospective chart review.Commentary on Holland et al. (2014): Opioid maintenance treatment--how much supervision is helpful?

P2860

Q33666935-AA783907-E1D4-43C3-AA99-08C94AEA3344 Q34952233-F148D7CC-1652-487E-9CC5-77AF4F12675B Q36198525-1BF5ADCC-2835-4A84-83A4-D4F3C75EB731 Q36263379-87770287-55E5-4872-9389-68B4DE42CA81 Q37637022-CB63E85D-4596-4BB5-8454-634B3711FB8E Q37721745-85024E44-0EF5-4A6D-9FE0-242340CB2842 Q38691415-0F7EB4A7-962B-4DA2-AFE5-186868C98721 Q44343792-8E99C89C-0AD3-4247-B10A-5B7FA5A65FD2

P2860

Predictive factors for relapse in patients on buprenorphine maintenance.

http://www.wikidata.org/entity/Q37580637

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Predictive factors for relapse in patients on buprenorphine maintenance.

@en

Predictive factors for relapse in patients on buprenorphine maintenance.

@nl

type

label

Predictive factors for relapse in patients on buprenorphine maintenance.

@en

Predictive factors for relapse in patients on buprenorphine maintenance.

@nl

prefLabel

Predictive factors for relapse in patients on buprenorphine maintenance.

@en

Predictive factors for relapse in patients on buprenorphine maintenance.

@nl

P1433

Q37580637-DE91D2B1-311A-41B0-8260-A8755BA20DA2

P1476

Q37580637-19D8319B-CEFF-4B2E-8115-E4681C8CF598

P2093

Q37580637-0C2A5480-60BD-4C93-8FE1-B867FDA95FD7

Q37580637-30C524D2-AB82-4BF2-A44B-CB1ACA295DAB

Q37580637-A900EBF7-AB4B-4264-A14C-860592028C8A

Q37580637-B92716B2-E524-4C37-9755-A96CFFB7C44E

P2860

Q37580637-3966480F-23E0-44CB-9F83-AE3F2B902D99

Q37580637-3BF269D9-9866-4AAF-96CA-CBC739F8EDBF

Q37580637-7678229D-9C29-4208-B61D-DC31BA01A115

Q37580637-87A3FB6A-553A-4843-892E-9DE34A2D2FEC

Q37580637-93DB3B45-D67D-4FDB-8697-2C99576EBCC0

Q37580637-AB845874-FF4A-4B99-ADB8-DE2BFF31EAD8

Q37580637-C99FEBE0-2192-425C-8F93-61A4A34807EC

Q37580637-CEC7BFBF-8FA6-414E-9B06-D27C83759948

Q37580637-D4121671-C7F7-477F-9D67-CCA65530071E

Q37580637-F588AF3D-8AEA-4AAC-AA2A-55FF548ACA06

P304

Q37580637-6256CECD-2EA0-4AAA-AC8D-1A5BD4ED0ECC

P31

Q37580637-0F2E90D5-22DB-4481-A4AB-F05577F91C4E

P356

Q37580637-0184CA35-6311-4924-AB01-42533BC91736

P433

Q37580637-256298FB-1465-43CC-89E5-131668868821

P478

Q37580637-FD31EAD9-5011-4D64-9082-EC6793751B33

P577

Q37580637-4B9B619E-3C53-4F95-A28E-7FE8AE644B9C

P5875

Q37580637-8FE01406-C345-4975-8536-85A4D8A89F38

P698

Q37580637-36784FB1-1166-4667-BCDC-F255C0B5C794

P932

Q37580637-1D7C37AC-74AD-4694-9599-CF3F85B43282

P356

J.1521-0391.2013.12074.X

P1433

American Journal on Addictions

P1476

Predictive factors for relapse in patients on buprenorphine maintenance.

@en

P2093

Alistair J Reid Finlayson

http://www.w3.org/2001/XMLSchema#string

Li Wang

http://www.w3.org/2001/XMLSchema#string

Michael Ferri

http://www.w3.org/2001/XMLSchema#string

Peter R Martin

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Clinical practice. Office-based treatment of opioid-dependent patients.

Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes.

Participant characteristics and buprenorphine dose.

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.

Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth

Effect of buprenorphine dose on treatment outcome.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

CDC grand rounds: prescription drug overdoses - a U.S. epidemic.

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

P304

62-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1521-0391.2013.12074.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259209855

http://www.w3.org/2001/XMLSchema#string

P698

24313243

http://www.w3.org/2001/XMLSchema#string

P932

3922612

http://www.w3.org/2001/XMLSchema#string